Multiple-variable dose regimen for treating TNFa-related disorders

Details for Australian Patent Application No. 2012213946 (hide)

Owner Abbott Biotechnology Ltd.

Inventors Chartash, Elliot; Granneman, George Richard; Hoffman, Rebeca S.; Yan, Philip; Taylor, Lori K.

Agent Spruson & Ferguson

Pub. Number AU-A-2012213946

Parent 2011218744

Filing date 14 August 2012

Wipo publication date 6 September 2012

International Classifications

C07K 16/24 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 38/00 Medicinal preparations containing peptides

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61K 39/40 Medicinal preparations containing antigens or antibodies - bacterial

A61P 17/06 Drugs for dermatological disorders

A61P 37/00 Drugs for immunological or allergic disorders

Event Publications

30 August 2012 Complete Application Filed

6 September 2012 Application Open to Public Inspection

  Published as AU-A-2012213946

13 September 2012 Corrigenda

  Applications OPI - Name Index Under the name Abbott Biotechnology Ltd., Application No. 2012213946, under INID (54) correct the title to read Multiple-variable dose regimen for treating TNFalpha-related disorders

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012213947-Springless trampoline assembly tool

2012213945-Smoke detector